Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests ; volume:6 ; number:1 ; day:17 ; month:10 ; year:2011 ; pages:1-10 ; date:12.2011
Orphanet journal of rare diseases ; 6, Heft 1 (17.10.2011), 1-10, 12.2011
- Urheber
-
Andreotti, Giuseppina
- Beteiligte Personen und Organisationen
-
Citro, Valentina
De Crescenzo, Agostina
Orlando, Pierangelo
Cammisa, Marco
Correra, Antonella
Cubellis, Maria Vittoria
SpringerLink (Online service)
- DOI
-
10.1186/1750-1172-6-66
- URN
-
urn:nbn:de:1111-2016050119712
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Andreotti, Giuseppina
- Citro, Valentina
- De Crescenzo, Agostina
- Orlando, Pierangelo
- Cammisa, Marco
- Correra, Antonella
- Cubellis, Maria Vittoria
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Drug repositioning can accelerate discovery of pharmacological chaperones
Targeted stabilization of Munc18‐1 function via pharmacological chaperones
Light‐Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological Chaperones
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
Molecular chaperones
Phosphorus Dendrimers for Metal‐Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease
Development of a pharmacorphore model for pharmacological chaperones targeting mutant trafficking-deficient CNG channels
Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study
Pharmacological Chaperones for β‐Galactosidase Related to G M1 ‐Gangliosidosis and Morquio B: Recent Advances
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Drug repositioning can accelerate discovery of pharmacological chaperones
Targeted stabilization of Munc18‐1 function via pharmacological chaperones
Light‐Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological Chaperones
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
Molecular chaperones
Phosphorus Dendrimers for Metal‐Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease
Development of a pharmacorphore model for pharmacological chaperones targeting mutant trafficking-deficient CNG channels
Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study
Pharmacological Chaperones for β‐Galactosidase Related to G M1 ‐Gangliosidosis and Morquio B: Recent Advances
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Drug repositioning can accelerate discovery of pharmacological chaperones
Targeted stabilization of Munc18‐1 function via pharmacological chaperones
Light‐Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological Chaperones
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
Molecular chaperones
Phosphorus Dendrimers for Metal‐Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease
Development of a pharmacorphore model for pharmacological chaperones targeting mutant trafficking-deficient CNG channels
Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study